Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Biocon Opens First US Manufacturing Facility in New Jersey, Invests USD 30 Million in Expansion

Biocon Pharma gets USFDA nod for deep vein thrombosis drug Rivaroxaban

Ruchika Sharma16 May 2025 2:57 PM IST

Bangalore: Biocon Pharma Limited, a wholly owned subsidiary of Biocon Limited, has received approval for its Abbreviated New Drug...

Former Coca-Cola executive Punita Lal joins Lupin Board as Additional Director

Ruchika Sharma16 May 2025 12:59 PM IST

Mumbai: Global pharma major Lupin Limited has appointed Punita Lal as an Additional Director (Non-Executive, Independent) to its Board of ...

Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made Mandatory

Lupin Rivaroxaban Tablets approved by USFDA

Ruchika Sharma16 May 2025 12:23 PM IST

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated...

Alembic Pharma appoints Jigr Shah as Head - Business Finance

Ruchika Sharma16 May 2025 11:30 AM IST

Vadodara: Alembic Pharma has announced the appointment of Jigr Shah as Head - Business Finance (Senior Management Personnel) of the Company."We...

Mankind Pharma bags CDSCO nod to start Phase 1 trials of Autoimmune drug candidate

Mankind Pharma hit with over Rs 341 crore additional tax demand from IT authority

Ruchika Sharma15 May 2025 5:41 PM IST

New Delhi: Mankind Pharma Limited has disclosed the receipt of orders from the IT Authority, raising additional tax demands (including interest) of Rs...

BioNTech to buy CureVac in USD 1.25 billion all-stock deal

GSK to acquire liver disease drug Efimosfermin for up to USD 2 billion

Ruchika Sharma15 May 2025 4:10 PM IST

London: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies for patients with...

Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK

USFDA clears Alembic Pharma cardio drug Rivaroxaban, launch expected in next year

Ruchika Sharma15 May 2025 3:26 PM IST

Vadodara: Alembic Pharmaceuticals Limited has announced that it has received final approval from the US Food & Drug Administration (USFDA)...

Unichem Labs Roha facility gets 3 USFDA observations

USFDA issues EIR for Zydus Lifesciences Ambernath facility

Ruchika Sharma15 May 2025 1:45 PM IST

Ahmedabad: Zydus Lifesciences has announced that the company has received the Establishment Inspection Report (EIR) report from...

Mercks SpringWorks Therapeutics gets nod for Ogsiveo from European Commission for adults with Desmoid Tumors

After Baclofen, now Gabapentin: Marksans Pharma arm bags another UK MHRA green light

Ruchika Sharma15 May 2025 12:56 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary in the UK, Relonchem Limited, has received Marketing...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck scores USFDA OK for Welireg for 12 years and older with pheochromocytoma or paraganglioma

Ruchika Sharma15 May 2025 11:45 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug Administration...

AbbVie completes acquisition of Capstan Therapeutics

AbbVie Emrelis gets USFDA accelerated approval for a type of lung cancer

Ruchika Sharma15 May 2025 11:10 AM IST

North Chicago: AbbVie has received accelerated approval from the U.S. Food and Drug Administration (FDA) for EMRELIS (telisotuzumab...

Shilpa Medicare Unit VI Bengaluru facility

Shilpa Pharma Lifesciences Unit 1 gets EIR from USFDA

Ruchika Sharma15 May 2025 10:15 AM IST

Karnataka: Shilpa Pharma Lifesciences, a 100% subsidiary of Shilpa Medicare Limited, has received an Establishment Inspection Report...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok